Soyasaponin Ab inhibits lipopolysaccharide-induced acute lung injury in mice

International Immunopharmacology

Volumn 30, Issue , 2016, Pages 121-128

  Lin, Jing ^a   Cheng, Yanwen ^a   Wang, Tao ^b   Tang, Lihua ^a   Sun, Yan ^a   Lu, Xiuyun ^a   Yu, Huimin ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Acute lung injury; LPS; LXR ; NF B; Soyasaponin Ab

Indexed keywords

ANTIINFLAMMATORY AGENT; CATALASE; CYCLOOXYGENASE 2; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIVER X RECEPTOR ALPHA; MYELOPEROXIDASE; NITRIC OXIDE; SAPONIN; SOYASAPONIN AB; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR; PTGS2 PROTEIN, MOUSE; SMALL INTERFERING RNA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; IN VITRO STUDY; LIVER PROTECTION; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SOYBEAN;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; ORPHAN NUCLEAR RECEPTORS; RNA, SMALL INTERFERING; SAPONINS; SOYBEANS; SUPEROXIDE DISMUTASE;

EID: 84949500344     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.12.001     Document Type: Article

References (44)

1. L. National Heart, A.C.T.N. Blood Institute, J.D. Truwit, G.R. Bernard, J. Steingrub, M.A. Matthay, and et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome N. Engl. J. Med. 370 2014 2191 2200
2. Z. Zhao, X. Tang, X. Zhao, M. Zhang, W. Zhang, S. Hou, and et al. Tylvalosin exhibits anti-inflammatory property and attenuates acute lung injury in different models possibly through suppression of NF-kappaB activation Biochem. Pharmacol. 90 2014 73 87
3. C.S. Park, B.R. Bang, H.S. Kwon, K.A. Moon, T.B. Kim, K.Y. Lee, and et al. Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase Biochem. Pharmacol. 84 2012 1660 1670
4. O. Syrkina, B. Jafari, C.A. Hales, and D.A. Quinn Oxidant stress mediates inflammation and apoptosis in ventilator-induced lung injury Respirology 13 2008 333 340
5. Y. Imai, K. Kuba, G.G. Neely, R. Yaghubian-Malhami, T. Perkmann, G. van Loo, and et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury Cell 133 2008 235 249
6. K. Atabai, and M.A. Matthay The pulmonary physician in critical care. 5: acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology Thorax 57 2002 452 458
7. G.D. Rubenfeld, E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, and et al. Incidence and outcomes of acute lung injury N. Engl. J. Med. 353 2005 1685 1693
8. L. Wang, Y. Xu, Q. Yu, Q. Sun, Y. Xu, Q. Gu, and et al. H-RN, a novel antiangiogenic peptide derived from hepatocyte growth factor inhibits inflammation in vitro and in vivo through PI3K/AKT/IKK/NF-kappaB signal pathway Biochem. Pharmacol. 89 2014 255 265
9. L. Feng, P. Song, H. Zhou, A. Li, Y. Ma, X. Zhang, and et al. Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice Biochem. Pharmacol. 89 2014 109 118
10. M.H. Kim, Y.J. Son, S.Y. Lee, W.S. Yang, Y.S. Yi, D.H. Yoon, and et al. JAK2-targeted anti-inflammatory effect of a resveratrol derivative 2,4-dihydroxy-N-(4-hydroxyphenyl)benzamide Biochem. Pharmacol. 86 2013 1747 1761
11. S. Uda, S. Spolitu, F. Angius, M. Collu, S. Accossu, S. Banni, and et al. Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages J. Lipid Res. 54 2013 3158 3169
12. Y.C. Chen, S.C. Shen, W.R. Lee, W.C. Hou, L.L. Yang, and T.J. Lee Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages J. Cell. Biochem. 82 2001 537 548
13. I. Rahman, and I. Adcock Oxidative stress and redox regulation of lung inflammation in COPD Eur. Respir. J. 28 2006 219 242
14. S. Ghosh, M.J. May, and E.B. Kopp NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16 1998 225 260
15. S.K. Manna Double-edged sword effect of biochanin to inhibit nuclear factor kappaB: suppression of serine/threonine and tyrosine kinases Biochem. Pharmacol. 83 2012 1383 1392
16. Y.W. Wang, A.H. Moser, J.K. Shigenaga, C. Grunfeld, and K.R. Feingold Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines J. Lipid Res. 46 2005 2377 2387
17. M. Canavan, C. McCarthy, N.B. Larbi, J.K. Dowling, L. Collins, F. O'Sullivan, and et al. Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-kappaBp50 Innate Immunity 2014
18. D. Wang, M. Liu, Y. Wang, M. Luo, J. Wang, C. Dai, and et al. Synthetic LXR agonist T0901317 attenuates lipopolysaccharide-induced acute lung injury in rats Int. Immunopharmacol. 11 2011 2098 2103
19. D. Zhao, M. Yan, Y. Huang, and X. Sun Efficient protocol for isolation and purification of different soyasaponins from soy hypocotyls J. Sep. Sci. 35 2012 3281 3292
20. N. Qiao, Q. Liu, H. Meng, and D. Zhao Haemolytic activity and adjuvant effect of soyasaponins and some of their derivatives on the immune responses to ovalbumin in mice Int. Immunopharmacol. 18 2014 333 339
21. I.A. Lee, Y.J. Park, E.H. Joh, and D.H. Kim Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages J. Agric. Food Chem. 59 2011 13165 13172
22. X. Chen, X. Yang, T. Liu, M. Guan, X. Feng, W. Dong, and et al. Kaempferol regulates MAPKs and NF-kappaB signaling pathways to attenuate LPS-induced acute lung injury in mice Int. Immunopharmacol. 14 2012 209 216
23. H. Lv, C. Zhu, Y. Liao, Y. Gao, G. Lu, W. Zhong, and et al. Tenuigenin ameliorates acute lung injury by inhibiting NF-kappaB and MAPK signalling pathways Respir. Physiol. Neurobiol. 216 2015 43 51
24. M.H. Liu, A.H. Lin, H.F. Lee, H.K. Ko, T.S. Lee, and Y.R. Kou Paeonol attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling Mediat. Inflamm. 2014 2014 651890
25. S. Bao, Y. Zou, B. Wang, Y. Li, J. Zhu, Y. Luo, and et al. Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages Int. Immunopharmacol. 28 2015 429 434
26. Y.C. Lin, Y.S. Lai, and T.C. Chou The protective effect of alpha-lipoic acid in lipopolysaccharide-induced acute lung injury is mediated by heme oxygenase-1 Evid. Based Complement. Alternat. Med. 2013 2013 590363
27. M.-H. Lin, M.-C. Chen, T.-H. Chen, H.-Y. Chang, and T.-C. Chou Magnolol ameliorates lipopolysaccharide-induced acute lung injury in rats through PPAR-γ-dependent inhibition of NF-kB activation Int. Immunopharmacol. 28 2015 270 278
28. Y. Fu, E. Zhou, Z. Wei, W. Wang, T. Wang, Z. Yang, and et al. Cyanidin-3-O-beta-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts Biochem. Pharmacol. 90 2014 126 134
29. E.H. Joh, W. Gu, and D.H. Kim Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-kappaB and MAPK pathways Biochem. Pharmacol. 84 2012 331 340
30. B. Raymond, L. Ravaux, S. Memet, Y. Wu, A. Sturny-Leclere, D. Leduc, and et al. Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation Biochem. Pharmacol. 79 2010 1149 1155
31. A. Fernandez-Bustamante, J. Klawitter, J.E. Repine, A. Agazio, A.J. Janocha, C. Shah, and et al. Early effect of tidal volume on lung injury biomarkers in surgical patients with healthy lungs Anesthesiology 121 2014 469 481
32. Z. Tianzhu, Y. Shihai, and D. Juan The effects of morin on lipopolysaccharide-induced acute lung injury by suppressing the lung NLRP3 inflammasome Inflammation 37 2014 1976 1983
33. W. Li, H. Huang, X. Niu, T. Fan, H. Hu, Y. Li, and et al. Tetrahydrocoptisine protects rats from LPS-induced acute lung injury Inflammation 37 2014 2106 2115
34. Q. Feng, Y. Ren, Y. Wang, H.Y. Ma, J. Xu, C.R. Zhou, and et al. Anti-inflammatory effect of SQC-beta-CD on lipopolysaccharide-induced acute lung injury J. Ethnopharmacol. 118 2008 51 58
35. C. Sittipunt, K.P. Steinberg, J.T. Ruzinski, C. Myles, S. Zhu, R.B. Goodman, and et al. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome Am. J. Respir. Crit. Care Med. 163 2001 503 510
36. A. Murakami, and H. Ohigashi Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals Int. J. Cancer 121 2007 2357 2363
37. C. Bowler, M. Montagu, and D. Inze Superoxide dismutase and stress tolerance Annu. Rev. Plant Biol. 43 1992 83 116
38. K. Dobashi, K. Pahan, A. Chahal, and I. Singh Modulation of endogenous antioxidant enzymes by nitric oxide in rat C6 glial cells J. Neurochem. 68 1997 1896 1903
39. H. Yu, M. Valerio, and J. Bielawski Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans J. Lipid Res. 54 2013 189 201
40. Q. Liu, H. Wu, S.M. Chim, L. Zhou, J. Zhao, H. Feng, and et al. SC-514, a selective inhibitor of IKKbeta attenuates RANKL-induced osteoclastogenesis and NF-kappaB activation Biochem. Pharmacol. 86 2013 1775 1783
41. S.B. Joseph, A. Castrillo, B.A. Laffitte, D.J. Mangelsdorf, and P. Tontonoz Reciprocal regulation of inflammation and lipid metabolism by liver X receptors Nat. Med. 9 2003 213 219
42. K. Smoak, J. Madenspacher, S. Jeyaseelan, B. Williams, D. Dixon, K.R. Poch, and et al. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense J. Immunol. 180 2008 3305 3312
43. L. Chang, Z. Zhang, W. Li, J. Dai, Y. Guan, and X. Wang Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kappaB pathway Biochem. Biophys. Res. Commun. 357 2007 772 778
44. M.A. Birrell, M.C. Catley, E. Hardaker, S. Wong, T.M. Willson, K. McCluskie, and et al. Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses J. Biol. Chem. 282 2007 31882 31890